NIFTY 50▲22,147.00
151.15 (0.69%)
SENSEX▲73,088.33
599.34 (0.83%)
NIFTY BANK▲47,574.15
504.70 (1.07%)
TATA MOTORS▼963.20
-8.15 (-0.84%)
INDIAN RAILWAY FINANCE CORP▼141.00
-0.95 (-0.67%)
SUZLON ENERGY▼39.35
-1.80 (-4.37%)
TATA POWER▼428.10
-1.65 (-0.38%)
TATA STEEL▲162.10
2.05 (1.28%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▼160.70
-2.45 (-1.50%)
RELIANCE INDUSTRIES▲2,940.25
11.60 (0.40%)
RELIANCE POWER▼28.05
-0.65 (-2.26%)
HDFC BANK▲1,531.30
36.60 (2.45%)
RAIL VIKAS NIGAM▼258.45
-1.45 (-0.56%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
JIO FIN SERVICES LTD▼370.10
-8.30 (-2.19%)
ADANI POWER▼594.55
-3.55 (-0.59%)
ZOMATO▲189.20
4.00 (2.16%)
NHPC▼87.15
-2.35 (-2.63%)
INDIAN RAILWAY TOURISM CORP▼992.00
-0.95 (-0.10%)
STATE BANK OF INDIA▲750.45
5.65 (0.76%)
INDIAN OIL CORP▼166.65
-2.35 (-1.39%)
MRF▼1,29,157.65
-73.85 (-0.06%)
ITC▲424.75
5.90 (1.41%)
ADANI GREEN ENERGY▼1,770.05
-5.40 (-0.30%)
ADANI ENTERPRISES▲3,026.95
7.65 (0.25%)
JAIPRAKASH POWER VENTURES▼17.05
-0.15 (-0.87%)
ADANI PORT & SEZ▲1,310.00
14.45 (1.12%)
Suven Life Sciences Share Price
SUVEN
₹106.15-₹3.85 (-3.5%) Past YearLast updated on 19 Apr, 2024 | 03:46 PM IST
₹105.00₹110.50
LH
What’s in news?
Company overview
About
Market cap
| Open₹108.90 | Close₹110.00 |
Circuit range₹115.50 - ₹104.50 | Day range₹105.00 - ₹110.50 | Year range₹55.10 - ₹129.00 |
Volume2,96,114 | Avg. traded₹107.14 | Revenue (12m)₹12 Cr |
Suven Life SciencesSuven Life Sciences Limited is an India-based biopharmaceutical company. The Company is engaged in the drug discovery and development of new chemical entities (NCEs) in central nervous system (CNS) disorders targeting unmet medical needs, globally. It operates through the research and development services segment. Its drug discovery & research/clinical pipeline include Masupirdine (SUVN-502) Neuropsychiatric Symptoms in Alzheimer's, Masupirdine (SUVN-502) Cognitive deficits in AD, Samelisant (SUVN-G3031) Narcolepsy, Samelisant (SUVN-G3031) Cognitive Disorders, Ropanicant (SUVN-911) Depressive Disorders, Usmarapride (SUVN-D4010), Cognitive Disorders, SUVN-I6107, Cognitive Disorders and Schizophrenia, SUVN-M8036, Psychiatric Disorders, and SUVN-D1044 Gastrointestinal Disorders. Its drug discovery & development support services (DDDSS) include synthetic and medicinal chemistry, analytical chemistry, in vitro biology, ADME, pharmacology, toxicology, bioanalysis, and NCE formulations.
Read more
Suven Life Sciences Key indicators
52 week high₹129.00 | 52 week low₹55.10 | P/E ratio |
P/B ratio7.86 | ROE-3.03% | ROCE-2.95% |
Dividend yield-- | Debt/Equity ratio | EPS-0.92 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin-140.8% | Net profit margin-148.66% |
ROE-3.03% | ROA-2.62% |
ROCE-2.95% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Suven Life Sciences Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Apr 19 2024 | ₹108.90 | ₹106.15 | -2.59% |
Thu, Apr 18 2024 | ₹113.75 | ₹110.00 | -3.41% |
Tue, Apr 16 2024 | ₹111.00 | ₹111.85 | |
Mon, Apr 15 2024 | ₹111.10 | ₹111.95 | |
Fri, Apr 12 2024 | ₹115.95 | ₹115.70 | -0.22% |
Wed, Apr 10 2024 | ₹115.30 | ₹116.60 | |
Tue, Apr 9 2024 | ₹121.50 | ₹115.30 | -5.38% |
Mon, Apr 8 2024 | ₹112.70 | ₹116.55 |
Events
Corporate actions
Rights Issue • 1:2
Ex date 17 Oct 2022
Learn more